Screening for mild thyroid failure is cost-effective
This article was originally published in Clinica
Executive Summary
The cost-effectiveness of screening for mild thyroid failure compares favourably with other preventive practices. These findings were reported by researchers from the Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, who screened 35-year-old patients with a serum assay for thyroid-stimulating hormone every five years.